Amalgamated Bank Gritstone Bio, Inc. Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$1.96 - $2.9 $9,206 - $13,621	-4,697 Reduced 61.35%	2,959 $8,000
Q4 2023 Feb 06, 2024	SELL	$1.28 - $2.85 $1,127 - $2,510	-881 Reduced 10.32%	7,656 $16,000
Q2 2023 Aug 11, 2023	BUY	$1.66 - $3.03 $14,171 - $25,867	8,537 New	8,537 $16,000
Q2 2022 Aug 15, 2022	SELL	$1.77 - $4.34 $9,104 - $22,324	-5,144 Closed	0 $0
Q1 2022 Jun 30, 2022	BUY	$4.03 - $12.19 $20,730 - $62,705	5,144 New	5,144 $21,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.